Association between TP53 gene ARG72PRO polymorphism and chromosome aberrations in human cancers

Molecular Carcinogenesis

Volumn 49, Issue 6, 2010, Pages 521-524

  Litviakov, Nicolay V ^a,b,c   Denisov, Evgeny V ^b,c   Takhauov, Ravil M ^a   Karpov, Andrey B ^a   Skobel'skaja, Elena V ^a   Vasil'eva, Elena O ^a   Goncharik, Olesya O ^a   Ageeva, Alena M ^a   Mamonova, Natalya V ^a   Mezheritskiy, Stanislav A ^a   Sevost'janova, Natalya V ^d   Koshel, Andrey P ^d  

^a Federal Physician of Biological Agency   (Russian Federation)

^b CANCER RESEARCH INSTITUTE   (Russian Federation)

^c TOMSK STATE UNIVERSITY   (Russian Federation)

^d SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Cancer; Chromosome aberrations; Polymorphism; TP53

Indexed keywords

ARGININE; PROLINE;

ADULT; ARTICLE; CANCER CLASSIFICATION; CHROMATID ABERRATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TP53 GENE; TUMOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; FEMALE; GENES, P53; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 77953907653     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20633     Document Type: Article

References (15)

1. Shu KX, Li B, Wu LX. The p53 network: p53 and its downstream genes. Colloids Surf B Biointerfaces 2007;55:10-18. (Pubitemid 46216062)
2. Keimling M, Wiesmuller L. DNA double-strand break repair activities in mammary epithelial cells - Influence of endogenous p53 variants. Carcinogenesis 2009;30:1260-1268.
3. Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: Cancer implications. Nat Rev Cancer 2009;9:95-107.
4. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999;19:1092-1100. (Pubitemid 29046852)
5. Dumont P, Leu JI, Della Pietra AC, George DL III, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003;33:357-365. (Pubitemid 36278852)
6. Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 2004;108:196-199. (Pubitemid 37541770)
7. Siddique M, Sabapathy K. Trp53-dependent DNA-repair is affected by the codon 72 polymorphism. Oncogene 2006;25:3489-3500. (Pubitemid 43901670)
8. Denisov EV, Cherdyntseva NV, Litvyakov NV, et al. TP53 mutations and Arg72Pro polymorphism in breast cancers. Cancer Genet Cytogenet 2009;192:93-95.
9. Hu Z, Li X, Yuan R, Ring BZ, Su L. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis. Breast Cancer Res Treat 2009. DOI: 10.1007/s10549-009-0488-9
10. Zhuo W, Zhang Y, Xiang Z, Cai L, Chen Z. Polymorphisms of TP53 codon 72 with breast carcinoma risk: Evidence from 12226 cases and 10782 controls. J Exp Clin Cancer Res 2009;28:115.
11. Wilson DM III, Bohr VA, McKinnon PJ. DNA damage, DNA repair, ageing and age-related disease. Mech Ageing Dev 2008;129:349-352.
12. Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 2004;149:309-334.
13. Kiuru A, Lindholm C, Heilimo I, et al. Influence of DNA repair gene polymorphisms on the yield of chromosomal aberrations. Environ Mol Mutagen 2005;46:198-205. (Pubitemid 41642312)
14. Skjelbred CF, Svendsen M, Haugan V, et al. Influence of DNA repair gene polymorphisms of hOGG1, XRCC1, XRCC3, ERCC2 and the folate metabolism gene MTHFR on chromosomal aberration frequencies. Mutat Res 2006;602:151-162.
15. Qiu YL, Wang W, Wang T, et al. Genetic polymorphisms, messenger RNA expression of p53, p21, and CCND1, and possible links with chromosomal aberrations in Chinese vinyl chloride-exposed workers. Cancer Epidemiol Biomarkers Prev 2008;17:2578-2584.